Linear mixed models (LMM) are widely used to estimate narrow sense heritability explained by tagged single-nucleotide polymorphisms (SNPs).
Introduction
For many phenotypes, there is a substantial difference between estimates of narrow sense heritability from family studies and variance explained by discovered single-nucleotide polymorphisms (SNPs) from genome-wide association studies (GWAS) [1, 2] . This gap is a key component of the missing heritability problem [3] . Existing genotyping technologies have allowed narrow sense heritability to be estimated from unrelated individuals using all SNPs in the genotyping platform (typically most common with a minor allele frequency >0.05) [4] . However, given that we cannot exclude the possibility of existing rare variants with large effects that have not been detected by genotyping arrays, this SNP-specific heritability is only a lower bound of the true narrow sense heritability. Nevertheless, we do not yet fully understand the gap between SNP heritability and the variance explained by replicated SNPs.
Several hypotheses have been postulated and investigated to explain this problem. Recent attempts suggest that previous estimates are biased and that large sample sizes are required to obtain accurate results [5, 6, 7] . Naturally, violation of model assumptions can result in biased estimates. For example, using a model that does not capture existing epistatic effects will risk biasing the SNP heritability estimates [6] . Moreover, LMM implicitly assumes that all SNPs have an effect on the phenotype as part of the infinitesimal assumption.
Violation of this assumption was thought to be a possible source of bias given used, the variance components are inaccurately estimated taking boundary values. These potential sources of bias are all associated with heritability estimates from variance components models.
The restricted maximum likelihood method (REML) [10] is the mainstream method for estimating variance components. It is implemented in a variety of genome-wide software packages, such as the genome-wide complex trait analysis GCTA [11] , efficient mixed-model association EMMA eXpedited [12] , FAST LMM [13] and the genome-wide efficient mixed-model association GEMMA [14] . All these methods are equivalent in the sense that they are all based on the same classical univariate LMM. Indeed, some of these methodse.g., EMMA, FAST LMM and GEMMA-even produce identical p-values in genetic association testing applications [14] . However, these methods differ in their computational complexity, with GEMMA being the most efficient in this regard [14] .
REML produces unbiased estimates of the variance components if they are allowed to be negative [15] ; otherwise, its estimates are very likely to degenerate in the boundary of the parameter space when small samples are used. When a variance parameter is estimated as zero, this should not imply that it is close to zero. Instead, it commonly indicates a large amount of uncertainty about it [16, 17, 18] . In multiple-phenotype models, the problem with estimates extends to another class of degeneracy, namely, non-positive definite estimates of the covariance matrices. Such estimates not only are uninterpretable but also can result in underestimated standard errors for the fixed-effect part of an LMM [19] . This feature is misleading in GWAS because an SNP of interest is typically tested by modeling its effect as fixed; therefore, an underestimated standard error will lead to overconfidence about the estimated effect.
Multivariate linear mixed models have recently emerged as a tool to increase statistical power by incorporating correlations among multiple phenotypes. Such models can be fitted using, for example, multi-trait mixedmodel MTMM [20] and GCTA [21] , both of which are limited to bivariate phenotypes. A popular multivariate method that extended the number of phenotypes to more than two was recently proposed by Zhou and Stephens and implemented in GEMMA software [22] . Both the univariate and multivariate versions of GEMMA are widely used in genetic epidemiology. Therefore, we use them as our benchmark given that they have one advantage over the aforementioned methods: speed [14, 22] . GEMMA relies on the maximum likelihood (ML) method including its restricted version. In this study, however we propose that an improved estimation is obtained using a full Bayes approach, specifically, the use of inverse Wishart (IW) prior for the covariance matrices and a diffuse normal distribution on the covariate coefficients.
Two key problems are addressed by our approach. First, it takes into account the tendency of the ML or REML estimates of the covariance matrices to be non-positive definite even when the number of phenotypes is not very large. Our approach overcomes this problem by adding an extra level of variability to the model through the assignment of a non-informative IW prior that allows the data to dominate while guarding against positive definiteness problems. Second, and as a result, the marginal heritability estimates are more efficient in terms of certainty than those from existing univariate and likelihoodbased methods.
The outline of this article is as follows. First, we provide some definitions and notations about the matrix-normal distribution. Second, we discuss the most commonly used model for multiple phenotypes and subsequently state the definition of marginal SNP heritability. Third, we unravel the equivalence between the multivariate model under study and the multivariate ridge regression. This equivalence indicates that the model has the advantage of including all tagged SNPs while accommodating inevitable correlations among them (linkage disequilibrium). The ridge representation is used further to (1) explain the degeneracy problem associated with estimates of the covariance matrices in genome-wide studies and (2) provide a fast evaluation of the posterior distribution of the SNP effect sizes, which can subsequently be used for predictions as model checking. In the last part of the Methods section, we present the complete Bayes model and its simplified form, which facilitates the use of many "off-the-shelf" Bayesian software programs. To show the benefits of the Bayesian multivariate model, we apply it to the expression of genes involved in a breast cancer pathway. We perform two types of comparisons:
Bayesian versus frequentist approaches and univariate versus multivariate approaches. Finally, we use a scaled version of the IW to assess for prior sensitivity.
Methods

Definitions and notations
The matrix-normal distribution is a generalization of the multivariate normal distribution, which allows us to model correlations among and within subjects [23] . The probability density function for the random matrix X has the following form:
Its expected value and second-order expectations are given by E[X]=M,
, respectively.
One way to understand how the matrix normal generalizes the multivariate normal distribution is to assume we have n 1-dimensional variates that are independent and identically distributed as normal with zero mean and variance . Because these variates are independent, concatenating them will result in a vector with a block diagonal covariance matrix
Multiple-phenotype model
We consider the matrix-variate model given by
where n and d are the number of individuals and phenotypes, respectively. Here, phenotype according to the multivariate model is defined as follows:
Clearly, this number increases rapidly with the number of phenotypes. Such a large number of parameters can make existing algorithms unstable, e.g., by
producing covariance matrices that are not positive definite and standard error matrices with large or sometimes uninterpretable entries (NAN). To explain these issues in more detail, it is instructive to first describe the nature of these covariance matrices or, in other words, their relation to SNP effect sizes. To this end, we proceed by writing the matrix-variate model in equation 2 in terms of SNP effect sizes. In statistics, this is referred to as ridge regression.
Generalized Bayesian interpretation of ridge regression
The Bayesian interpretation of ridge regression assumes that the regression coefficients of a multiple regression are independent and identically normally distributed [24] . Here, we aim to provide a broader Bayesian interpretation of ridge regression in the context of matrix-normal distribution. Consider the matrix-normal regression model of p SNP effects on d phenotypes:
with matrix-normal prior to the effect sizes 1 
Similarly, the prior on the effect sizes is written as follows:
which is itself equivalent to
Here, vec refers to matrix vectorization. Now,
The multivariate normal equivalence of model 2 without β X is given as follows: shows that the multiple-phenotype model has the advantage of handling linkage disequilibrium in an integrative manner, i.e., without the need for an initial LD pruning step (see [25] for relevant discussion on how ridge regression handles LD).
Boundary estimation problem
To understand the causes of non-positive definite estimates of the genetic covariance matrix Σ , it is easier to think of model 2 using its equivalent form from the ridge regression representation as follows: with v=d, d+1 and d+2 were randomly generated (supplementary note)). The least informative IW corresponds to v=d+1, and use of this parameter combination has the effect of setting an approximate uniform distribution on the genetic correlations.
Simplified full Bayes model
Using univariate LMM, Lippert et al. [13] showed that a spectrally transformed model using a spectral decomposition of the relatedness matrix significantly reduces computational complexity. Similar approaches were subsequently adopted by [26, 22, 14] . Following these developments, we spectrally decompose the relatedness matrix, which allows us to write the matrix-variate model in 
where U is an Eventually, the full Bayes model will have the following hierarchical structure:
Here, 
Results
The MuTHER study
One of the main aims of the MuTHER consortium [27] is to quantify the variation in gene expression that is due to genetic factors and ultimately provides insights into the mechanisms underlying the disease susceptibility of associated SNPs. To this end, genome-wide expression profiles (Illumina HT-12v3 Chip) and genome-wide association data (Illumina 610k or 1M chip) were obtained from three tissues adipose, skin and lymphoblastoid cell lines (LCL) from blood samples of 856 Caucasian female twins aged 38.7 to 86.6 years and living throughout the United Kingdom. All recruited females were from the TwinsUK adult registry [28, 29] .
We used the SNPs from the original study, which were filtered at a MAF >0.01 and IMPUTE info value >0.6, resulting in a total number of SNPs p=2,238,276. We also used the filtered list of probes given by [27] , which excluded polymorphic probes and probes mapping to multiple genes or to genes of uncertain function given that these data are difficult to interpret.
Our model is not tailored for twins in the sense that it does not consider the shared environment, which can result in inflated heritability estimates.
Accordingly, we chose to analyze one individual of each twin pair in addition to the available singletons, resulting in a number of individuals suitable for the analysis (N=446). There were no differences in batch effects after removing the twin structure; therefore, only age was included as a non-genotype covariate.
The expressions were downloaded directly from ArrayExpress, and access to the genotypes and covariates was granted from the TwinsUK Steering Committee.
Heritability estimation
To illustrate the benefits of our Bayesian multivariate approach, we applied it to a pre-defined gene set from the MuTHER project, namely, genes in a breast cancer pathway [30] . We chose 20 filtered genes comprising d=30 filtered probes. We implemented the simplified full Bayes model as a module for the existing and widely used Bayesian analysis software rjags and coda [31, 32] . We performed two types of comparisons to characterize the variability in the heritability estimates: Bayesian versus frequentist approaches and univariate versus multivariate approaches. In each scenario, confidence and credible intervals of the heritability estimates were inspected to assess their uncertainty.
For univariate likelihood-based analysis, GEMMA software was used to obtain heritability estimates, which also facilitates the use of Wald's method to compute confidence intervals. The model was separately fitted to each probe when d=1 using its gene expression as a response variable and the genotypes as explanatory variables modeled via a random term. Figure 1 presents the Wald's confidence intervals for the univariate likelihood-based heritability of each probe. The confidence intervals are wide. In many cases, the intervals spread beyond the parameter space (e.g., including negative values for heritability), which make them difficult to interpret.
For a better characterization of the variability in the heritability estimates, a
Bayesian univariate model was used. The model is based on a diffuse gamma prior for the scalar precisions: G(0.001,0.001) with a unity mean and variance of 1000. The Bayesian estimates from the univariate analysis differ significantly from their REML counterparts (figures 1 and 2) as both remain susceptible to variability. Thus, the variance/uncertainty remained large despite the very large number of iterations (see [33] for relevant discussion). Convergence is further discussed below.
Although GEMMA can theoretically be applied to any number of phenotypes, when we attempted to fit 5 probes from the breast cancer pathway using the filtered set of individuals (N=446), the numerical algorithm failed to produce valid standard error matrices. In addition, the covariance matrices were not positive definite because of the small sample size and large covariance matrices. We overcame this problem by assigning the IW prior, as described above.
The 
Model assessment
Based on credible intervals, the results from the BC pathway support the idea that Bayesian multivariate models produce more accurate estimates of SNP heritability than classical multivariate and univariate models. It is also clear that the genetic architectures of complex phenotypes are miscellaneous, and no single method will be the most efficient in capturing all of them. The "gold standard" for model assessment and comparison is therefore an improved phenotype prediction using a new data set. This method can be performed first by estimating the effect sizes using the computationally efficient formula for the mode of their posterior distribution
then incorporating the formula to obtain the predicted phenotypic values of the new sample based on its genotypes
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These results were recorded after a 150,000 burn-in period using a sample of 5000 resulting from 25,000 iterations with a thinning interval of 5.
Here, y=vec(Y) and the effect sizes
are the values estimated from the original data. The prediction algorithm is delineated in the supplementary note.
In our example, phenotype prediction as a model checking technique has its pitfalls. In the breast cancer pathway, our method produced expression heritability estimates that are close to zero. The exception was CHURC1, with a relatively higher heritability. Therefore, any attempt to predict the expression using SNPs is expected to fail because the heritability (variance explained by genotyped SNPs) is very low. Accordingly, we had to resort to alternative approaches in an attempt to provide evidence in support of our SNP heritability estimates. The approaches were (1) finding literature that could support or refute the results and (2) using more flexible prior specifications.
Literature support
To trace back the heritability estimates, we looked at previously reported cis eQTLs for the 20 genes from the MuTHER study tested here. According to Grundberg et al. [27] , there are 196 SNPs associated with CHURC1 expression, . Given that GEMMA fits an LMM with the fixed-effect part being the genotypes of the tested SNP, proximal contamination [34] ; that is the situation when the tested SNP is assumed both fixed and random, can incur power loss. To eliminate this issue, we followed the GCTA approach and excluded chromosome 14 from the computations of the relatedness matrix. In addition to the 180 SNPs identified before the exclusion, only one additional significant SNP was detected because of a slight decrease in most of the p-values after the exclusion. Overall, there is a significant overlap between the SNPs from our analysis and those obtained by Grundberg et al. [27] .
It would be interesting to determine what effect excluding the detected eQTLs would have on the heritability estimates. To this end, we repeated the analysis, excluding the SNPs previously associated with CHURC1 expression from the model, and the trace plots for its heritability appeared unstable using the same burn-in period and thinning interval that was used before the exclusion. We therefore explored additional convergence diagnostics, leading to the choice of a million iterations with a thinning interval of 1000 after a similar burn-in period of 150,000. Nevertheless, convergence remained an issue for the heritability of CHURC1. However, the heritability of each of the remaining genes remained close to zero with acceptable convergence.
The lack of convergence for the heritability of CHURC1 after excluding its eQTLs recapitulates the boundary estimation problem: the expected polygenic variance is zero (assuming neither epistatic nor very small effects). However, given that we are sampling from a family of positive definite matrices, the 1 resulting estimate will not be zero, which probably caused the lack of convergence. See the supplementary note for convergence diagnostics.
Prior sensitivity analysis
Possible arguments against the use of the IW are (1) the uncertainty for all variance parameters are controlled by a single degree of freedom, namely v=d+1, and (2) the lack of independence between the variances and the correlations. To overcome the first issue and alleviate the second, we used a scaled version of the IW. . This prior will not shrink the correlations, so their marginal prior will remain uniform when v= d+1. However, the variances now can be estimated more freely from the data. To determine the scaling needed, we added another level of variability by assigning a uniform prior U(0, 100) for each scaling parameter (see supplementary for the relevant BUGS code). The SNP heritability estimates using the SIW are very similar to those obtained using the unscaled method ( figure 4) , implying that the above concerns that plague the IW do not affect the posterior distributions of the heritability.
Discussion
In conclusion, we developed a multivariate Bayesian approach for SNP heritability estimation. Our approach can be seen as an extension of existing Finally, the results from the SNP heritability estimation of the expression of the tested BC pathway genes, specifically CHURC1, and its eQTLs are provocative and underscore the need to investigate CHURC1 effect on breast cancer status. We have made the first promising steps toward designing a method orthogonal to the one in this paper to investigate the extent to which significant heritability estimates of the expression of BC-related genes will translate into improved predictive accuracy of BC status. 
